N/A
Completed N=143
Magnesium is Associated With QoL in COPD: A Cross-sectional Study
Source: ClinicalTrials.gov NCT01564953 ↗Enrolled (actual)
143
Serious AEs
—
Results posted
Mar 2017
Primary outcomePrimary: Serum Vitamin D — 75.13 mmol/L
Summary
The aim of this study was to investigate the associations between serum concentrations of vitamin D, Magnesium and Calcium in Chronic obstructive pulmonary disease patients and the potential impact of these parameters on lung function and quality of life.
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Serum Vitamin D |
75.13 | — |
| SECONDARY Lung Function Test |
52 | — |
| SECONDARY Serum Magnesium |
0.82 | — |
| SECONDARY Serum Calcium |
1.23 | — |
| SECONDARY Quality of Life |
24 | — |
Eligibility Criteria
Inclusion Criteria
- COPD-patients
- Unchanged medical treatment for COPD for the last 4 weeks
- Outpatients
- adults over 40 years
Exclusion Criteria
- COPD exacerbation, which resulted in hospitalization and/or modification of medical treatment within 4 weeks
- Patients with other lung diseases, such as active tuberculosis, lung cancer, sarcoidosis and pulmonary fibrosis
- diseases affecting vitamin D and/or calcium and/or magnesium distribution
- Previous lung resection
- Treatment with systemic steroids
- Known addiction problems with alcohol and/or drugs
Data sourced from ClinicalTrials.gov (NCT01564953). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.